halts

GENEVA (Reuters) - The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality. The setback came as the WHO also reported more than 200,000 new cases globally of the disease…

ZURICH (Reuters) - Swiss drugmaker Novartis (NOVN.S) is halting its trial of malaria drug hydroxychloroquine (HCQ) against COVID-19 after struggling to find participants, it said on Friday, as data emerged from other studies raising doubts about its efficacy. FILE PHOTO: A pharmacist displays a box of Hydroxychloroquine at the CHR Centre Hospitalier Regional de la…

The World Health Organisation has decided to hat trials of  hydroxychloroquineWHO says the antimalarial drug is  being withdrawn from its multi-country Solidarity Trial of potential treatmentsThe announcement comes two days after the US withdrew emergency use authorisations for both hydroxychloroquine and chloroquineGeneva - The World Health Organisation said it had decided on Wednesday to halt…

WHO has praised China for its eagerness towards the prospect of scientific inquiries into determining the origins of COVID-19. The number of coronavirus cases in Russia has climbed to 353,427, with 8,946 new infections in the past 24 hours. The United States has barred arrivals from Brazil, the country with the second-highest number of cases in the…

Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.The World Health Organization said it will temporarily halt global trials of hydroxychloroquine – the malaria drug President Trump said he was recently  taking to prevent the coronavirus infection – and chloroquine after a study showed that hospitalized coronavirus patients taking…